| |
| |
|
| Insider
Information: |
Biogen Ma Inc. |
| Relationship: |
10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
37,204,182 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$232,995,077 |
|
|
| Total
Shares |
37,204,182 |
|
|
| Total
Value |
$232,995,077 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sangamo Biosciences Inc |
SGMO |
10% Owner |
|
0 |
2023-09-26 |
17,652,466 |
Premium* |
|
|
Denali Therapeutics Inc. |
DNLI |
10% Owner |
|
0 |
2020-09-22 |
13,310,243 |
Premium* |
|
|
Sage Therapeutics, Inc. |
SAGE |
10% Owner |
|
0 |
2020-12-31 |
6,241,473 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SGMO |
Sangamo Biosciences Inc |
10% Owner |
– – • |
2023-09-26 |
4 |
S |
$0.50 |
$3,000,000 |
I/I |
(6,000,000) |
17,652,466 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
10% Owner |
– – • |
2022-08-30 |
4 |
S |
$5.27 |
$526,520 |
I/I |
(100,000) |
23,652,466 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
10% Owner |
– – • |
2022-08-29 |
4 |
S |
$5.33 |
$2,130,720 |
I/I |
(400,000) |
23,752,466 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
10% Owner |
– – • |
2021-12-28 |
4 |
S |
$8.51 |
$23,522 |
I/I |
(2,764) |
24,152,466 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
10% Owner |
– – • |
2021-12-27 |
4 |
S |
$8.56 |
$5,136 |
I/I |
(600) |
24,155,230 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
10% Owner |
– – • |
2021-12-23 |
4 |
S |
$8.55 |
$694,530 |
I/I |
(81,187) |
24,155,830 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
10% Owner |
– – • |
2021-12-09 |
4 |
S |
$8.56 |
$202,541 |
I/I |
(23,660) |
24,237,017 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
10% Owner |
– – • |
2021-12-08 |
4 |
S |
$8.64 |
$654,828 |
I/I |
(75,814) |
24,260,677 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
10% Owner |
– – • |
2021-12-07 |
4 |
S |
$8.52 |
$444,437 |
I/I |
(52,178) |
24,336,491 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
10% Owner |
– – • |
2021-12-02 |
4 |
S |
$8.51 |
$15,943 |
I/I |
(1,874) |
24,388,669 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
10% Owner |
– – • |
2021-12-01 |
4 |
S |
$8.52 |
$6,223 |
I/I |
(730) |
24,390,543 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
10% Owner |
– – • |
2021-11-26 |
4 |
S |
$8.60 |
$248,434 |
I/I |
(28,884) |
24,391,273 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
10% Owner |
– – • |
2020-12-31 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
6,241,473 |
|
- |
|
| DNLI |
Denali Therapeutics Inc. |
10% Owner |
– – • |
2020-09-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
13,310,243 |
|
% |
|
| SGMO |
Sangamo Biosciences Inc |
10% Owner |
– – • |
2020-04-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
24,420,157 |
|
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
